-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PEN-866 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PEN-866 in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PEN-866 in Colorectal Cancer Drug Details: PEN-866 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PEN-866 in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PEN-866 in Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PEN-866 in Ovarian Cancer Drug Details: PEN-866 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PEN-866 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PEN-866 in Gastric Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PEN-866 in Gastric Cancer Drug Details: PEN-866 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PEN-866 in Pancreatic Ductal Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PEN-866 in Pancreatic Ductal Adenocarcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PEN-866 in Pancreatic Ductal Adenocarcinoma Drug Details: PEN-866 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EBTATE in Neuroendocrine Tumors
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EBTATE in Neuroendocrine Tumors report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EBTATE in Neuroendocrine Tumors Drug Details: 177-Lu-DOTA-EB-TATE is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRO-1160 in Follicular Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRO-1160 in Follicular Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRO-1160 in Follicular Lymphoma Drug Details: PRO-1160 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Efruxifermin in Liver Cirrhosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Efruxifermin in Liver Cirrhosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Efruxifermin in Liver Cirrhosis Drug Details: Efruxifermin (AKR-001) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Debio-0228 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Debio-0228 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Debio-0228 in Solid Tumor Drug Details: Debio-0228 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Debio-0228 in Pancreatic Ductal Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Debio-0228 in Pancreatic Ductal Adenocarcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Debio-0228 in Pancreatic Ductal Adenocarcinoma Drug Details: Debio-0228 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Debio-0228 in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Debio-0228 in Metastatic Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Debio-0228 in Metastatic Colorectal Cancer Drug Details: Debio-0228 is under...